Feng Wang
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanc Colorectal Cancer Metastatic | — | 2024-11-15 |
| Unknown | Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Esophageal Cancer | Phase 3 | 2021-12-05 |
| Completed | Anlotinib Retrospective Study for Esophageal Cancer Esophageal Neoplasms | — | 2019-01-01 |